Josef Coresh, MD, PhD

Josef Coresh, MD, PhD

Johns Hopkins University

H-index: 194

North America-United States

Professor Information

University

Johns Hopkins University

Position

___

Citations(all)

325644

Citations(since 2020)

150275

Cited By

228465

hIndex(all)

194

hIndex(since 2020)

135

i10Index(all)

878

i10Index(since 2020)

767

Email

University Profile Page

Johns Hopkins University

Research & Interests List

Aging

vascular disease

dementia

kidney disease

epidemiology

Top articles of Josef Coresh, MD, PhD

Description of the Baseline Audiologic Characteristics of the Participants Enrolled in the Aging and Cognitive Health Evaluation in Elders Study

Purpose The Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study is a randomized clinical trial designed to determine the effects of a best-practice hearing intervention versus a successful aging health education control intervention on cognitive decline among community-dwelling older adults with untreated mild-to-moderate hearing loss. We describe the baseline audiologic characteristics of the ACHIEVE participants. Method Participants aged 70–84 years (N = 977; Mage = 76.8) were enrolled at four U.S. sites through two recruitment routes: (a) an ongoing longitudinal study and (b) de novo through the community. Participants underwent diagnostic evaluation including otoscopy, tympanometry, pure-tone and speech audiometry, speech-in-noise testing, and provided self-reported hearing abilities. Baseline characteristics are reported as frequencies (percentages) for categorical variables or …

Authors

Victoria A Sanchez,Michelle L Arnold,Joshua F Betz,Nicholas S Reed,Sarah Faucette,Elizabeth Anderson,Sheila Burgard,Josef Coresh,Jennifer A Deal,Ann Clock Eddins,Adele M Goman,Nancy W Glynn,Lisa Gravens-Mueller,Jaime Hampton,Kathleen M Hayden,Alison R Huang,Kaila Liou,Christine M Mitchell,Thomas H Mosley Jr,Haley N Neil,James S Pankow,James R Pike,Jennifer A Schrack,Laura Sherry,Katherine H Teece,Kerry Witherell,Frank R Lin,Theresa H Chisolm,ACHIEVE Collaborative Study

Journal

American Journal of Audiology

Published Date

2024/3/4

Large-scale proteomics identifies novel biomarkers and circulating risk factors for aortic stenosis

Background Limited data exist regarding risk factors for aortic stenosis (AS). The plasma proteome is a promising phenotype for discovery of novel biomarkers and potentially causative mechanisms. Objectives The aim of this study was to discover novel biomarkers with potentially causal associations with AS. Methods We measured 4,877 plasma proteins (SomaScan aptamer-affinity assay) among ARIC (Atherosclerosis Risk In Communities) study participants in mid-life (visit 3 [V3]; n = 11,430; age 60 ± 6 years) and in late-life (V5; n = 4,899; age 76 ± 5 years). We identified proteins cross-sectionally associated with aortic valve (AV) peak velocity (AVmax) and dimensionless index by echocardiography at V5 and with incident AV-related hospitalization after V3 with the use of multivariable linear and Cox proportional hazard regression. We assessed associations of candidate proteins with changes in AVmax over …

Authors

Khaled Shelbaya,Victoria Arthur,Yimin Yang,Pranav Dorbala,Leo Buckley,Brian Claggett,Hicham Skali,Line Dufresne,Ta-Yu Yang,James C Engert,George Thanassoulis,James Floyd,Thomas R Austin,Anna Bortnick,Jorge Kizer,Renata CC Freitas,Sasha A Singh,Elena Aikawa,Ron C Hoogeveen,Christie Ballantyne,Bing Yu,Josef Coresh,Michael J Blaha,Kunihiro Matsushita,Amil M Shah

Journal

Journal of the American College of Cardiology

Published Date

2024/2/6

Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study

This study investigates correlates of anti-S1 antibody response following COVID-19 vaccination in a U.S. population-based meta-cohort of adults participating in longstanding NIH-funded cohort studies. Anti-S1 antibodies were measured from dried blood spots collected between February 2021-August 2022 using Luminex-based microsphere immunoassays. Of 6245 participants, mean age was 73 years (range, 21-100), 58% were female, and 76% were non-Hispanic White. Nearly 52% of participants received the BNT162b2 vaccine and 48% received the mRNA-1273 vaccine. Lower anti-S1 antibody levels are associated with age of 65 years or older, male sex, higher body mass index, smoking, diabetes, COPD and receipt of BNT16b2 vaccine (vs mRNA-1273). Participants with a prior infection, particularly those with a history of hospitalized illness, have higher anti-S1 antibody levels. These results suggest that …

Authors

John S Kim,Yifei Sun,Pallavi Balte,Mary Cushman,Rebekah Boyle,Russell P Tracy,Linda M Styer,Taison D Bell,Michaela R Anderson,Norrina B Allen,Pamela J Schreiner,Russell P Bowler,David A Schwartz,Joyce S Lee,Vanessa Xanthakis,Margaret F Doyle,Elizabeth A Regan,Barry J Make,Alka M Kanaya,Sally E Wenzel,Josef Coresh,Carmen R Isasi,Laura M Raffield,Mitchell SV Elkind,Virginia J Howard,Victor E Ortega,Prescott Woodruff,Shelley A Cole,Joel M Henderson,Nicholas J Mantis,Monica M Parker,Ryan T Demmer,Elizabeth C Oelsner

Journal

Nature Communications

Published Date

2024/2/19

PRENATAL CARE AMONG WOMEN WITH PRE-PREGNANCY CARDIOMETABOLIC RISK FACTORS

BackgroundPre-pregnancy obesity, diabetes and hypertension are prevalent among reproductive-age women in the US and are associated with adverse maternal and neonatal outcomes. While prenatal care mitigates these risks, many individuals do not receive adequate prenatal care. We evaluated the incidence and timing of prenatal care initiation among women with pre-pregnancy cardiometabolic risk factors.MethodsUsing data from the National Vital Statistics System between 2017-2019 (n= 13,460,936), we compared timing of prenatal care among self-reported race/ethnicity groups, stratified by maternal cardiometabolic risk factors.ResultsPrevalence of pre-pregnancy obesity, diabetes, and hypertension were 28.0%, 0.9%, and 1.9%, respectively. Most individuals initiated prenatal care in the first trimester. Individuals who identified as Non-Hispanic Native Hawaiian and Other Pacific Islander (NHOPI) and …

Authors

Chloe Duvall,Theresa Boyer,Arthur Vaught,Chiadi E Ndumele,Allison Hays,Erin D Michos,Josef Coresh,Anum Minhas

Journal

Journal of the American College of Cardiology

Published Date

2024/4/2

Identification of plasma proteins for early detection of cancer, including lung, in the Atherosclerosis Risk in Communities (ARIC) study

Background: Plasma proteins, directly secreted from tumor cells or a result of the body’s response to a tumor, may have utility for early detection. We aimed to identify plasma protein combinations that predict prediagnostic cancers in a prospective study. Methods: We sampled from 8,186 ARIC study participants without a cancer diagnosis at blood draw and with 4,877 log2-transformed proteins measured by SomaScan. We selected as cases those diagnosed within 5 years after blood draw and were registry/medical record confirmed. We selected as controls those who never had a cancer history by 2015 and did not die of cancer. Participants with possible liver, kidney, or inflammatory conditions were excluded (eGFR-cr<30, top 1% of plasma AST, ALT, CRP). Highly correlated proteins (r>±0.75), abundant or known markers (albumin, CRP, PSA), and proteins with wide log2-transformed distributions (SD>1 and >10 …

Authors

Meng Ru,Christopher Douville,Kenneth R Butler,Corinne E Joshu,Jiayun Lu,Anna Prizment,Josef Coresh,Elizabeth A Platz

Journal

Cancer Research

Published Date

2024/3/22

Urine Biomarkers of Kidney Tubule Health and Risk of Incident CKD in Persons Without Diabetes: The ARIC, MESA, and REGARDS Studies

Rationale & ObjectiveTubulointerstitial damage is a feature of early chronic kidney disease (CKD), but current clinical tests capture it poorly. Urine biomarkers of tubulointerstitial health may identify risk of CKD.Study DesignProspective cohort (ARIC) and case-cohort (MESA and REGARDS).Setting & ParticipantsAdults with eGFR ≥60 mL/min/1.73m2 and without diabetes in the ARIC, REGARDS, and MESA studies.ExposureBaseline urine monocyte chemoattractant protein-1 (MCP-1), alpha-1-microglobulin (α1m), kidney injury molecule-1 (KIM-1), epidermal growth factor (EGF), and chitinase-3-like protein 1 (YKL-40).OutcomeIncident CKD or ESKD (end-stage kidney disease).Analytical ApproachMultivariable Cox proportional hazards regression for each cohort; meta-analysis of results from all three cohorts.Results872 ARIC participants (444 cases of incident CKD), 636 MESA participants (158 cases), and 924 …

Authors

Jonathan G Amatruda,Ronit Katz,Casey M Rebholz,Mark J Sarnak,Orlando M Gutierrez,Sarah J Schrauben,Jason H Greenberg,Josef Coresh,Mary Cushman,Sushrut Waikar,Chirag R Parikh,Jeffrey R Schelling,Manasi P Jogalekar,Joseph V Bonventre,Ramachandran S Vasan,Paul L Kimmel,Joachim H Ix,Michael G Shlipak,CKD Biomarkers Consortium

Journal

Kidney Medicine

Published Date

2024/4/26

Genomic and phenotypic correlates of mosaic loss of chromosome Y in blood

Mosaic loss of Y (mLOY) is the most common somatic chromosomal alteration detected in human blood. The presence of mLOY is associated with altered blood cell counts and increased risk of Alzheimer's disease, solid tumors, and other age-related diseases. We sought to gain a better understanding of genetic drivers and associated phenotypes of mLOY through analyses of whole genome sequencing of a large set of genetically diverse males from the Trans-Omics for Precision Medicine (TOPMed) program. This approach enabled us to identify differences in mLOY frequencies across populations defined by genetic similarity, revealing a higher frequency of mLOY in the European American (EA) ancestry group compared to those of Hispanic American (HA), African American (AA), and East Asian (EAS) ancestry. Further, we identified two genes (CFHR1 and LRP6) that harbor multiple rare, putatively deleterious variants associated with mLOY susceptibility, show that subsets of human hematopoietic stem cells are enriched for activity of mLOY susceptibility variants, and that certain alleles on chromosome Y are more likely to be lost than others.

Authors

Yasminka A Jakubek,Xiaolong Ma,Adrienne M Stilp,Fulong Yu,Jason Bacon,Justin W Wong,Francois Aguet,Kristin Ardlie,Donna Arnett,Kathleen Barnes,Joshua C Bis,Tom Blackwell,Lewis C Becker,Eric Boerwinkle,Russell P Bowler,Matthew J Budoff,April P Carson,Jiawen Chen,Michael H Cho,Josef Coresh,Nancy Cox,Paul S de Vries,Dawn L DeMeo,David W Fardo,Myriam Fornage,Xiuqing Guo,Michael E Hall,Nancy Heard-Costa,Bertha Hidalgo,Marguerite Ryan Irvin,Andrew D Johnson,Eimear E Kenny,Dan Levy,Yun Li,Joao AC Lima,Yongmei Liu,Ruth JF Loos,Mitchell J Machiela,Rasika A Mathias,Braxton D Mitchell,Joanne Murabito,Josyf C Mychaleckyj,Kari North,Peter Orchard,Stephen CJ Parker,Yash Pershad,Patricia A Peyser,Katherine A Pratte,Bruce Psaty,Laura M Raffield,Susan Redline,Stephen S Rich,Jerome I Rotter,Sanjiv J Shah,Jennifer A Smith,Aaron P Smith,Albert Smith,Margaret Taub,Hemant K Tiwari,Russell Tracy,Bjoernar Tuftin,Alexander G Bick,Vijay G Sankaran,Alexander P Reiner,Paul Scheet,Paul L Auer

Journal

medRxiv

Published Date

2024

Loneliness and social Network characteristics among older adults with hearing loss in the ACHIEVE study

Background Hearing loss is linked to loneliness and social isolation, but evidence is typically based on self-reported hearing. This study quantifies the associations of objective and subjective hearing loss with loneliness and social network characteristics among older adults with untreated hearing loss. Methods This study uses baseline data (N = 933) from the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study. Hearing loss was quantified by the better ear, speech-frequency pure tone average (PTA), Quick Speech-in-Noise test, and hearing-related quality of life. Outcomes were validated measures of loneliness and social network characteristics. Associations were assessed by Poisson, negative binomial, and linear regression adjusted for demographic, health, and study design characteristics. Results Participants were mean of 76.8 (4.0 …

Authors

Alison R Huang,Nicholas S Reed,Jennifer A Deal,Michelle Arnold,Sheila Burgard,Theresa Chisolm,David Couper,Nancy W Glynn,Theresa Gmelin,Adele M Goman,Lisa Gravens-Mueller,Kathleen M Hayden,Christine Mitchell,James S Pankow,James Russell Pike,Victoria Sanchez,Jennifer A Schrack,Josef Coresh,Frank R Lin,ACHIEVE Collaborative Research Group Galasko Doug Buring Julie Dubno Judy Greene Tom Lustig Larry

Journal

The Journals of Gerontology: Series A

Published Date

2024/2/1

Professor FAQs

What is Josef Coresh, MD, PhD's h-index at Johns Hopkins University?

The h-index of Josef Coresh, MD, PhD has been 135 since 2020 and 194 in total.

What are Josef Coresh, MD, PhD's research interests?

The research interests of Josef Coresh, MD, PhD are: Aging, vascular disease, dementia, kidney disease, epidemiology

What is Josef Coresh, MD, PhD's total number of citations?

Josef Coresh, MD, PhD has 325,644 citations in total.

What are the co-authors of Josef Coresh, MD, PhD?

The co-authors of Josef Coresh, MD, PhD are Andrew S. Levey, Elizabeth Selvin, Kunihiro Matsushita, Morgan Grams.

Co-Authors

H-index: 182
Andrew S. Levey

Andrew S. Levey

Tufts University

H-index: 109
Elizabeth Selvin

Elizabeth Selvin

Johns Hopkins University

H-index: 89
Kunihiro Matsushita

Kunihiro Matsushita

Johns Hopkins University

H-index: 77
Morgan Grams

Morgan Grams

Johns Hopkins University

academic-engine

Useful Links